PLANO, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer and a complete partner in innovation, will exhibit at Compamed 2023 from November 13-16, in Düsseldorf, Germany. Integer can be found in Hall 8b / N29.
During Compamed, Integer looks forward to connecting with medical device OEMs and start-ups to discuss its comprehensive suite of solutions from prototype to pilot and beyond. Integer’s focal points for Compamed 2023 revolve around the company’s significant investments in Europe, particularly in Ireland.
Integer has recently undertaken a strategic expansion of its site in New Ross, Ireland, covering an additional 80,000 square feet to substantially increase its high-volume guidewire and wire-based manufacturing capacity. Alongside the New Ross expansion, Integer has also invested in a new R&D and manufacturing facility in Galway, Ireland. The first construction phase of this new facility will add approximately 70,000 square feet of R&D and manufacturing space. This expansion aims to provide local solutions for structural heart, neurovascular, and electrophysiology applications, enabling seamless transitions from R&D to operations.
Further amplifying the company’s presence in Ireland, Integer’s team of experts in Spiddal, Ireland, specializes in complex braiding, textile, and impact coating and covering capabilities. The team offers comprehensive solutions, including medical textiles, absorbable stents, and biomaterial braiding, among others.
“We are committed to delivering unparalleled value to our partners,” said Payman Khales, President, Cardio & Vascular. “With our recent expansions in Europe, we’re dramatically strengthening our local and global differentiated R&D and manufacturing capabilities. Our aim is to streamline the supply chain and ensure a smooth transition from R&D to operations for both our European and global customers, helping to accelerate time to market for new product innovations.”
Medical device OEMs, start-ups and all interested parties are invited to visit Hall 8b / N29 during Compamed from November 13-16, 2023, to learn more about how Integer can serve as your complete partner in innovation.
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. The Company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, the Company develops batteries for high-end niche applications in energy, military, and environmental markets. The Company's brands include Greatbatch Medical®, Lake Region Medical® and Electrochem®. Additional information is available at www.integer.net
Investor Relations: Andrew Senn This email address is being protected from spambots. You need JavaScript enabled to view it. 763.951.8312 | Media Relations: Kelly Butler This email address is being protected from spambots. You need JavaScript enabled to view it. 214.618.4216 |
Last Trade: | US$109.92 |
Daily Change: | 0.14 0.13 |
Daily Volume: | 228,588 |
Market Cap: | US$3.680B |
April 25, 2024 February 15, 2024 February 01, 2024 January 16, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB